UnitedHealthcare |
Vimpat (Dspk) (lacosamide) |
Drugs for the Nervous System : Drugs for Seizures /Personality Disorder/Nerve Pain |
- Prior Authorization: Neurology: Epilepsy:
Documented Diagnosis: Yes
Duration: 12 Month(s)
- Neurology: Epilepsy:
Duration: 12 Month(s)
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: No
Duration of Reauthorization: N/A
Diagnosis Type(s): Partial-Onset Seizures
Used as Adjunctive Treatment: No
Duration of Failure or Adjunctive Treatment with Other Antiepileptic Product: >= 8 week(s)
Documented history of persisting seizures after titration to highest tolerated dose of each AED.: Yes
Lack of compliance as a reason for treatment failure has been ruled out: Yes
Documentation of treatment failure due to intolerable side effects.: Yes
Positive Response to Therapy Required for Reauth: No
Treatment for Age 17 years or older: No
Treatment for Age 1-16 years old: No
History of >= to 30 day trial of other AED required: No
Reapproval based on response: No
- Step Therapy: Neurology: Epilepsy:
ST Multiple Generics
|